Market Tracker

08/31 5:16pm ET

Celldex Therapeutics Inc (NASDAQ:CLDX)

3.32
Delayed Data
As of 4:00pm ET
 -0.11 / -3.21%
Today’s Change
2.96
Today|||52-Week Range
18.62
-78.83%
Year-to-Date
3 Reasons Celldex Therapeutics, Inc. Stock Could Fall
Aug 26 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close3.43
Today’s open3.41
Day’s range3.29 - 3.42
Volume1,726,038
Average volume (3 months)2,536,914
Market cap$344.9M
Dividend yield--
Data as of 4:00pm ET, 08/31/2016

Growth & Valuation

Earnings growth (last year)+0.76%
Earnings growth (this year)-2.10%
Earnings growth (next 5 years)--
Revenue growth (last year)+52.82%
P/E ratioNM
Price/Sales277.69
Price/Book1.17

Competitors

 Today’s
change
Today’s
% change
TRIBTrinity Biotech PLC-0.06-0.45%
LNTHLantheus Holdings In...-0.07-0.73%
IMMUImmunomedics Inc+0.01+0.36%
OXFDOxford Immunotec Glo...-0.04-0.38%
Data as of 4:15pm ET, 08/31/2016

Financials

Next reporting dateOctober 27, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$5.5M
Annual profit (last year)-$127.2M
Net profit margin-2,321.11%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
CFO, Secretary, Treasurer &
Senior Vice President
Avery W. Catlin
Corporate headquarters
Hampton, New Jersey

Forecasts